S100A9 is also upregulated in many cancer types, including breast cancer, colon cancer, hepatocellular carcinoma, gastric cancer, colorectal cancer, non-small-cell lung cancer and cervical cancer [40, 43]. Here, S100A9 is linked to malignant colon neoplasm.